Gastroenterology
Partner With Us
Advertisement

Liver Disease

thumb description

October 20, 2025

FDA Okays First Oral GLP-1 for CV Risk

Novo Nordisk’s once-daily GLP-1 tablet reduced major adverse cardiovascular events in high-risk adults, including those without prior heart attack or stroke.

Conexiant

thumb description

October 14, 2025

Do Quadruple Therapies Beat Triple for H. pylori?

Concomitant and bismuth quadruple regimens cleared ~90% of patients and outperformed triple therapy; sequential achieved ~84%. Adherence remained ~97% despite higher but manageable side effects.

Conexiant

thumb description

October 02, 2025

A New Hub for Liver Research Tackles Its First Investigations

Mount Sinai's newly launched Institute for Liver Research has funded its first two pilot projects, chosen from among 11 applications submitted by basic, translational, or clinical research teams, and awarded one-year grants of $30,000 each in hopes of generating preliminary data sufficient to stimulate broader funding and research collaborations. One project focuses on genomics and genetic sequencing of patients to determine how many and which abnormalities are linked to liver disease, while the other proposes to develop a lipid nanoparticle platform for hepatic stellate cell-specific drug delivery.

Mount Sinai New York

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.